Log In

Term Description

The most common challenges are Adrenocorticotropic hormone (ACTH) and human chorionic gonadotropin (hCG).

Part Descriptions

LP14493-8   Androstenedione
Androstenedione (also known as 4-androstenedione) is a 19-carbon steroid hormone produced in the adrenal glands and the gonads as an intermediate step in the biochemical pathway that produces the androgen testosterone and the estrogens estrone and estradiol. It is the common precursor of male and female sex hormones. Some androstenedione is also secreted into the plasma, and may be converted in peripheral tissues to testosterone and estrogens. Androstenedione originates either from the conversion of dehydroepiandrosterone or from 17-hydroxyprogesterone. It is further converted to either testosterone or estrone. The production of adrenal androstenedione is governed by ACTH, while production of gonadal androstenedione is controled by gonadotropins. In premenopausal women the adrenal glands and ovaries each produce about half of the total androstendione (about 3 mgday). Copyright Text is available under the Creative Commons Attribution/Share-Alike License. See http://creativecommons.org/licenses/by-sa/3.0/ for details. Source: Wikipedia, Androstenedione (Wikipedia)

LP14493-8   Androstenedione
Testing for androstenedione is used to diagnose viralizing syndromes including congenital adrenal hyperplasia, female virilization, hirsutism, polycystic ovarian disease, Stein-Levethal syndrome. and to detect abuse of anabolic steroids. It is also a drug- an anabolic steroid- used to enhance atheletic performance, but banned as an OTC drug by the FDA in 2004. Source: Regenstrief Institute

LOINC Names Get Info

Fully-Specified Name
Androstenedione^30M post XXX challenge:SCnc:Pt:Ser/Plas:Qn:
Long Common Name
Androstenedione [Moles/volume] in Serum or Plasma --30 minutes post XXX challenge
Short Name
Androst 30M p chal SerPl-sCnc
Display Name
Androstenedione 30 Min post Unsp challenge [Moles/Vol]
Consumer Name Alpha Get Info
Androstenedione 30 min after challenge, Blood

Part Model Get Info

  • Component
    Androstenedione^30M post XXX challenge
    LP304920-4
    • Analyte
      Androstenedione
      LP14493-8
      • Component Numerator
        Androstenedione
        LP14493-8
        • Component Numerator Core
          Androstenedione
          LP14493-8
        • Component Numerator Core Suffix
          NULL
           
      • Component Denominator
        NULL
         
        • Component Denominator Core
          NULL
           
        • Component Denominator Core Suffix
          NULL
           
    • Challenge
      30M post XXX challenge
      LP20458-3
    • Adjustment
      NULL
       
    • Count
      NULL
       
  • Property
    SCnc
    LP6860-3
  • Time
    Pt
    LP6960-1
  • System
    Ser/Plas
    LP7576-4
    • System Core
      Ser/Plas
      LP7576-4
    • Super System
      NULL
       
  • Scale
    Qn
    LP7753-9
  • Method
    NULL
     

Basic Attributes

Class
CHAL
Type
Laboratory
First Released
Version 2.52
Last Updated
Version 2.52 (MIN)
Order vs. Observation
Observation

Member of these Groups Get Info

LOINC GroupGroup Name
LG50187-0Androstenedione^30M post XXX challenge|Pt|Ser/Plas

Language Variants Get Info

TagLanguageTranslation
cs-CZCzech (Czechia)Androstendion^30 minut po zátěži XXX:Látková koncentrace:Časový bod:Sérum/plazma:Kvantitativní:
el-GRGreek (Greece)Ανδροστενεδιόνη^30 λεπτά κατόπιν πρόκλησης XXX:SCnc:Pt:Ορός/Πλάσμα:Qn:
Synonyms: 30 λεπτά κατόπιν πρόκλησης XXX CHAL Pt Qn SCnc Ανδροστενεδιόνη κατόπιν πρόκλησης XXX Ορός Ορός/Πλάσμα Πλάσμα Πρόκληση
es-ESSpanish (Spain)Androstenediona^30 minutos pos provocación XXX:Concentración de sustancia:Punto temporal:Suero o Plasma:Qn:
Synonyms: Cuantitativo
es-MXSpanish (Mexico)Androstenediona ^30M después del desafío XXX:Concentración de sustancias:Punto temporal:Suero o Plasma:Cuantitativo:
et-EEEstonian (Estonia)Androsteendioon^30 minutit pärast XXX manustamist:SCnc:Pt:S/P:Qn:
Synonyms: Aine kontsentratsioon Juhuslik Kvantitatiivne Plasma Seerum Seerum või plasma
fr-CAFrench (Canada)Androstènedione^30 min post test de provocation XXX:Concentration de substance:Temps ponctuel:Sérum/Plasma:Quantitatif:
fr-FRFrench (France)Androstènedione^T30min après épreuve:Moles/Volume:Ponctuel:Sérum/Plasma:Numérique:
fr-BEFrench (Belgium)Androstènedione^30 min post test de provocation XXX:Concentration de substance:Temps ponctuel:Sérum/Plasma:Quantitatif:
it-ITItalian (Italy)Androstenedione^30Minuti post XXX provocazione:SCnc:Pt:Siero/Plasma:Qn:
Synonyms: 30 minuti dopo XXX provocazione Concentrazione di Sostanza dopo XXX provocazione Plasma Punto nel tempo (episodio) Siero Siero o Plasma Stimolo Test di provocazione
nl-NLDutch (Netherlands)androsteendion^30 min na XXX belasting:mol/volume:moment:serum of plasma:kwantitatief:
Synonyms: 30M na XXX belasting
pl-PLPolish (Poland)Androstendion^30min po XXX obciążeniu:stężenie molowe:punkt w czasie:surowica lub osocze:ilościowy:
Synonyms: 30 minut po obciążeniu XXX po obciążeniu XXX
ru-RURussian (Russian Federation)Андростендион^30 минут после XXX пробы:МолКонц:ТчкВрм:Сыв/Плаз:Колич:
Synonyms: Количественный Молярность;Молярная объёмная концентрация Плазма Провокационная проба Сыворотка Сыворотка или Плазма Точка во времени;Момент
tr-TRTurkish (Turkey)Androstenediyon^30dk snr XXX girişimi:SubKons:Zmlı:Ser/Plaz:Kant:
zh-CNChinese (China)雄烯二酮^在XXX刺激之后30分钟:物质的量浓度:时间点:血清/血浆:定量型:
Synonyms: 0.5Hr之后于XXX刺激;0.5Hr之后于此处不作说明的刺激;0.5小时之后于XXX刺激;0.5小时之后于此处不作说明的刺激;30Min之后于XXX刺激;30Min之后于此处不作说明的刺激;30分钟之后于XXX刺激;30分钟之后于此处不作说明的刺激;在XXX刺激之后0.5Hr;在XXX刺激之后0.5小时;在XXX刺激之后30Min;在此处不作说明的刺激之后0.5Hr;在此处不作说明的刺激之后0.5小时;在此处不作说明的刺激之后30Min;在此处不作说明的刺激之后30分钟 Androst;gamma-4-雄烯二酮;gamma-4-雄甾烯二酮;γ-4-雄烯二酮;γ-4-雄甾烯二酮;雄甾烯二酮 XXX刺激 - 在...之后 XXX刺激因素 之后于 XXX 刺激;之后于 XXX 刺激因素;之后于此处不作说明的刺激;之后于此处不作说明的刺激因素;在 XXX 刺激因素之后;在此处不作说明的刺激之后;在此处不作说明的刺激因素之后 之后于... 克分子浓度;克分子浓度(单位体积);摩尔浓度;摩尔浓度(单位体积);物质的量浓度(单位体积) 刺激因素;挑战 可用数量表示的;定量性;数值型;数量型;连续数值型标尺 在...以后 在后 时刻;随机;随意;瞬间 此处不作说明的刺激 此处不作说明的刺激因素 血清或血浆

Example Units

UnitSource
nmol/LExample UCUM Units

LOINC Terminology Service (API) using HL7® FHIR® Get Info

CodeSystem lookup
https://fhir.loinc.org/CodeSystem/$lookup?system=http://loinc.org&code=77608-8